3655 NOBEL DRIVE, SAN DIEGO, CA
Market cap: $19.9M (12/18/2025)
Price: $2.09
Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
Earnings Release
Investor Presentation
Other Events
Interim Phase 3 Results Support Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly Contraceptive
News, Material Contracts
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Offering Statement
Correspondence
Submission Upload